Heart Disease


A successful blind date is all about finding common ground: a favorite food, a beloved band, or a shared hobby. For Natalie and James, medtech was the missing link. When they first met, Natalie was just four weeks out of her most recent open heart surgery. James had already spent more than 20 years living with diabetes and using an array of medical devices: insulin pumps, continuous glucose monitors, and advanced needle technology, to name a few.

Everyone’s experienced it: the feeling you get after running very fast. Your heart rate is up, you are short of breath and can feel dizzy or faint. For most people, the feeling goes away after a few moments of rest. But for Brandon Cobia, this was not the case. The Alabama resident and father of two had been living for months with a resting heart rate of 170-180, which is similar to the heart rate of someone who has just completed a 26.2 mile marathon. Within a six-month period, he endured several procedures to correct his condition, called atrial tachycardia, which is a type of arrhythmia known as a supraventricular tachycardia (SVT).

The medical technology industry is continually advancing and developing new innovations that improve the health and well-being of patients worldwide.

What is Heart Disease?

Heart Disease comprises a number of different conditions, many of which are related to a condition known as atherosclerosis – the buildup of plaque in the walls of arteries. Heart diseases include heart attacks, ischemic strokes, heart failure, arrhythmia, and heart valve problems.1

The Value of MedTech To Treat AFib

Millions of Americans Suffer from AFib

Atrial fibrillation (also called AFib or AF) is the most common type of irregular heartbeat, or arrhythmia.1 A normal heart beats 60-100 times per minute. During an AFib episode, a person’s heart can beat 175 times or more per minute.2  
Often undiagnosed, AFib prevalence estimates vary between 2.7 million and 6.1 million Americans affected.3 Age is a major risk factor for AFib – at age 60, 1 in 25 Americans has AFib. This number increases to 1 in 10 at age 80.4  

Image of Dr. Yock

Dr. Yock is driven by the need to improve health care and patient outcomes.


Studies show that AFib patients who undergo catheter ablation have a risk of stroke that is less than half that of patients on medications alone.

Image of Gloria

Glorida Moss didn't want to undergo open-heart surgery. So she found a medtech alternative, known as a transcatheter aoritc valve replacement.

Image of Iman

Without innovative medical technology and the courage of her doctors and family, Iman Dorty’s son Liam might have never known his mother.

Abiomed Impella

Noel was told he had a 20 percent chance of surviving, but innovative medical technology beat those odds.